GLP-1 in New York: Coverage, Costs & How to Get It
New York Medicaid doesn't cover GLP-1 medications for weight loss — only for type 2 diabetes, with prior authorization. For most residents that leaves two routes: private insurance, where coverage varies by plan, or cash-pay telehealth, which is available statewide.
New York at a glance
- Medicaid
- Not covered for weight loss (covered for diabetes)
- Private insurance
- Coverage varies by plan
- Cash pay
- Options from ~$69/mo
- Availability
- Telehealth available statewide
Full New York Medicaid detail ↓Hide New York Medicaid detail ↑
New York Medicaid does not appear among the small set of states (roughly 11–13 in 2026) that cover GLP-1 medications specifically for weight loss. GLP-1s are still covered for type 2 diabetes. Because policies change, confirm the current status with New York Medicaid.
GLP-1s such as Ozempic and Mounjaro are covered for type 2 diabetes in nearly every state Medicaid program, typically with prior authorization. The differentiator is the obesity (weight-loss) indication: New York is not among the roughly 11–13 states whose Medicaid covers it in 2026.
Coverage is also in flux nationally: a federal Medicaid demonstration (the BALANCE model) aims to expand access to obesity medications beginning in 2026, but participation is state-by-state and New York’s involvement isn’t yet confirmed.
Coverage rules change; confirm current status directly with New York Medicaid.
3 ways to get GLP-1 in New York
Which route makes the most sense depends on your coverage.
Medicaid
Not covered for weight lossBest for: people who qualify for diabetes-related coverage.
Private / employer
Coverage varies by planBest for: people with employer or private insurance (usually a prior authorization and BMI threshold apply). Programs like Ro coordinate branded medication and insurance.
Cash telehealth
No insurance requiredBest for: straightforward self-pay access, shipped statewide (see costs below).
What GLP-1 costs in New York
- Branded (Wegovy / Zepbound) — cash
- Full list price without coverage
- Branded — with insurance
- If your plan covers it (varies widely)
- Compounded semaglutide — telehealth
- No insurance needed; ships to New York
- Compounded tirzepatide — telehealth
- The stronger dual-agonist molecule
- Oral GLP-1 pills (Foundayo / oral Wegovy) — cash
- Newer prescription pills, direct from the maker; ship to New York
Cash prices are nationwide provider pricing (these programs serve New York); they are provider-reported and change, and compounded availability depends on FDA shortage status. Confirm current pricing before you buy.
Prefer a pill to a weekly injection? Two FDA-approved GLP-1 pills — orforglipron (Foundayo) and oral Wegovy — can now be prescribed to New York residents. See our full guide to GLP-1 weight-loss pills for how well they work, dosing and cost.
Who qualifies in New York
GLP-1 for weight management is generally for adults with a BMI of 30+, or 27+ with a weight-related condition (high blood pressure, high cholesterol, sleep apnoea or type 2 diabetes). The clinical criteria are the same in New York as nationwide — a prescriber makes the final call.
How to start in New York
- 1.Check any private or employer plan first — some cover branded GLP-1 with a prior authorization; New York Medicaid won't for weight loss.
- 2.If you're paying cash, complete a short online assessment with a licensed telehealth program.
- 3.A prescriber reviews your history and, if appropriate, prescribes.
- 4.A licensed pharmacy ships the medication to your door in New York — often within days.
- 5.Follow up as your dose is titrated over the first weeks.
Best GLP-1 programs available in New York
Our independent ranking of licensed telehealth programs that ship compounded GLP-1 to New York without insurance. Scores are ours; prices are provider-reported.
- #19.9/10
Best overall — lowest transparent flat price
$69/mo (compounded semaglutide) · Trustpilot 3.8 / 5
Ships to most US states
- #29.6/10
Lowest entry price, plus a brand-name option
$89/mo (compounded semaglutide)
Ships to most US states
- #39.4/10
Best for ongoing clinical guidance
Competitive (varies by plan — not a single flat number) · Trustpilot 3.7 / 5
Ships to most US states
View 3 more programs available in New York ↓Hide additional programs ↑
- #4SHEDBest introductory discount9.2/10
- #5HealthRxFast overnight cold-chain shipping9.0/10
- #6SynergyRXClosest medical supervision9.0/10
Medicare & special coverage
Medicare Part D still excludes drugs prescribed purely for weight loss — the same in New York as nationwide. A temporary Medicare GLP-1 Bridge demonstration (July 2026–Dec 2027) offers Wegovy, Zepbound or Foundayo for a $50 copay to eligible members, and GLP-1s remain covered for approved medical indications such as type 2 diabetes.
New York GLP-1: common questions
Does New York Medicaid cover GLP-1 for weight loss?+
New York Medicaid does not appear among the small set of states (roughly 11–13 in 2026) that cover GLP-1 medications specifically for weight loss. GLP-1s are still covered for type 2 diabetes. Because policies change, confirm the current status with New York Medicaid.
Does New York Medicaid cover Zepbound or Wegovy in New York?+
New York Medicaid doesn't cover Zepbound or Wegovy for weight loss. GLP-1s like Ozempic and Mounjaro can be covered for type 2 diabetes with prior authorization, but the weight-loss (obesity) indication is excluded from New York's Medicaid benefit. Confirm current rules with New York Medicaid.
Does New York Medicaid cover Ozempic in New York?+
Ozempic (semaglutide) is generally covered by New York Medicaid when it's prescribed for type 2 diabetes, usually with prior authorization — the diabetes indication is covered far more readily than weight loss across New York's Medicaid benefit. If you want a GLP-1 specifically for weight loss, coverage depends on whether New York covers the obesity indication at all. Confirm current rules with New York Medicaid.
How much does GLP-1 cost in New York without insurance?+
Branded GLP-1 at a New York pharmacy runs about $1,000–$1,400 a month at cash price. Compounded GLP-1 through a licensed telehealth program is far cheaper — from about $69/month for semaglutide and $119/month for tirzepatide — shipped to New York with no insurance required.
Can I get GLP-1 online in New York?+
Yes. Licensed telehealth programs operate in New York: a prescriber reviews your case and a licensed pharmacy ships the medication to your door. It doesn't depend on New York Medicaid and is the lowest-cost route for most residents.
Who qualifies for GLP-1 in New York?+
GLP-1 for weight management is generally appropriate for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, high cholesterol, sleep apnoea or type 2 diabetes. A prescriber confirms whether it's right for you — the clinical criteria are the same in New York as nationwide.
Does Medicare cover GLP-1 in New York?+
Medicare Part D still excludes drugs prescribed purely for weight loss, the same in New York as everywhere. A temporary federal demonstration (July 2026–Dec 2027) offers Wegovy, Zepbound or Foundayo for a $50 copay to eligible members, and GLP-1s remain covered for approved medical indications such as type 2 diabetes.
Can I get tirzepatide online in New York?+
Yes. Compounded tirzepatide — the dual GLP-1/GIP molecule in Zepbound and Mounjaro — is available to New York residents through licensed telehealth from about $119/month, no insurance required. Brand-name Zepbound is a separate, insurance-oriented route (see the cost table above).
Can I get GLP-1 pills in New York?+
Yes. Two FDA-approved GLP-1 weight-loss pills — orforglipron (Foundayo) and oral Wegovy (oral semaglutide 25 mg) — can be prescribed to New York residents, including direct from the manufacturers for roughly $149–$349 a month. They're a needle-free option, though the strongest injections still produce more weight loss. See our full GLP-1 pills guide for details.
Are compounded GLP-1 medications available in New York?+
Yes, through licensed telehealth programs that use US compounding pharmacies. Compounded semaglutide and tirzepatide are not FDA-approved finished drugs, and their availability can shift with FDA shortage status — always confirm a program uses a licensed pharmacy (our provider safety check helps).
Sources & references
Clinical figures on this page trace to peer-reviewed trials and official regulators. We link the primary record so you can verify it yourself.
- 1.KFF. Medicaid Coverage of and Spending on GLP-1s.Policy analysisKFF (Kaiser Family Foundation)
- 2.KFF. Status of State Medicaid Expansion Decisions.Policy analysisKFF (Kaiser Family Foundation)
- 3.Stateline. States retreat from covering drugs for weight loss (2025).Policy analysisStateline
- 4.KFF. What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge.Policy analysisKFF (Kaiser Family Foundation)
- 5.CDC. Adult Obesity Prevalence Maps (2023, BRFSS self-reported).RegulatoryU.S. Centers for Disease Control and Prevention
- 6.Medicare Rights Center. GLP-1 Weight-Loss Drug Demonstration Begins July 2026.Policy analysisMedicare Rights Center
Methodology:coverage status is drawn from KFF and Stateline reporting and each state’s published Medicaid policy; expansion status is from KFF; obesity figures are the CDC’s 2023 self-reported estimates. Program scores are our own editorial assessment. We may earn a commission when you sign up through a link on this page — it never changes our rankings.